NCT05327101

Brief Summary

Prospective, non-randomized, multi-center study designed to quantify patient preferences pertaining to risks and features of conventional transvenous pacemakers and leadless pacemakers

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
117

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

11 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 28, 2022

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

April 4, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 14, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 13, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 13, 2023

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

February 20, 2025

Completed
Last Updated

February 20, 2025

Status Verified

January 1, 2025

Enrollment Period

1.2 years

First QC Date

April 4, 2022

Results QC Date

July 11, 2024

Last Update Submit

January 30, 2025

Conditions

Outcome Measures

Primary Outcomes (9)

  • Mean Rankings for Pacemaker Device Features

    Ranking of six pacemaker device features from most concerning (1) to least concerning (6)

    Baseline

  • Results From RPL Model of Discrete Choice Experiment Choice Questions - Preference Weights (Effect-coded Parameters)

    The preference weights for the RPL model. Effect-coded parameters generate log-odds preference weights representing the relative strength of preference for each attribute level versus the mean effect across levels normalized at zero. A higher weight indicates a more preferred level while a lower weight indicates a less preferred level.

    Baseline

  • Results From RPL Model of Discrete Choice Experiment Choice Questions- Standard Deviations

    The standard deviations representing the degree of variation in preference weights, with larger estimates representing preference heterogeneity.

    Baseline

  • Maximum-acceptable Risks of a Complication

    Maximum-acceptable risk (MAR) of a complication was calculated for patients based off latent-class analysis with two groups-leadless class and transvenous class (see secondary outcome Constrained 2-class Latent-class model preference weights). The MAR represents risk level patients would be willing to accept to obtain their preferred pacemaker type, no discomfort, a device with longer battery life, and a device with more time since regulatory approval.

    Baseline

  • Maximum-acceptable Risks of an Infection

    Maximum-acceptable risk (MAR) of an infection was calculated for patients based off latent-class analysis with two groups-leadless class and transvenous class (see secondary outcome Constrained 2-class Latent-class model preference weights). The MAR represent the risk that patients would be willing to accept to obtain their preferred pacemaker type, no discomfort, a device with longer battery life, and a device with more time since regulatory approval.

    Baseline

  • Probability of Choosing Specified Pacemakers - All 3 Profiles

    Preference weight estimates were used to calculate the predicted probabilities that patients would choose a hypothetical pacemaker profile out of three different pacemaker types- leadless pacemaker removable, leadless pacemaker non-removable, or pacemaker with leads. Attributes for each pacemaker profile were defined using historical or published values. Preference weights from the latent class model were used to compute the probability that respondents within each class preference would choose a pacemaker profile over another.

    Baseline

  • Probability of Choosing Specified Pacemakers - Leadless Pacemaker Removable vs. Leadless Pacemaker Non-removable

    Preference weight estimates were used to calculate the predicted probabilities that patients would choose a hypothetical pacemaker profile out of three different pacemaker types- leadless pacemaker removable or leadless pacemaker non-removable. Attributes for each pacemaker profile were defined using historical or published values. Preference weights from the latent class model were used to compute the probability that respondents within each class preference would choose a pacemaker profile over another.

    Baseline

  • Probability of Choosing Specified Pacemakers - Leadless Pacemaker Removable vs. Pacemaker With Leads

    Preference weight estimates were used to calculate the predicted probabilities that patients would choose a hypothetical pacemaker profile out of three different pacemaker types- leadless pacemaker removable or pacemaker with leads. Attributes for each pacemaker profile were defined using historical or published values. Preference weights from the latent class model were used to compute the probability that respondents within each class preference would choose a pacemaker profile over another.

    Baseline

  • Probability of Choosing Specified Pacemakers - Leadless Pacemaker Non-removable vs. Pacemaker With Leads

    Preference weight estimates were used to calculate the predicted probabilities that patients would choose a hypothetical pacemaker profile out of three different pacemaker types- leadless pacemaker non-removable or pacemaker with leads. Attributes for each pacemaker profile were defined using historical or published values. Preference weights from the latent class model were used to compute the probability that respondents within each class preference would choose a pacemaker profile over another.

    Baseline

Secondary Outcomes (3)

  • Constrained 2-class Latent-class Model Preference Weights

    Baseline

  • Number of Discrete Choice Experiment Questions Answered

    Baseline

  • Association of Patient Characteristics With Membership in the Transvenous Class Versus the Leadless Class

    Baseline

Interventions

Patient preference survey on implantable cardiac pacemaker systems

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

300 patients

You may qualify if:

  • Able to read and speak English to consent to participate in the survey
  • Willing and able to use a tablet or computer to complete the survey
  • Scheduled to undergo evaluation for a de novo cardiac pacemaker at the study site (patient may or may not have a known indication for a pacemaker at the time)

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (11)

Honor Health

Scottsdale, Arizona, 85258, United States

Location

Arrhythmia Research Group

Jonesboro, Arkansas, 72401, United States

Location

Arkansas Heart Hospital

Little Rock, Arkansas, 72211, United States

Location

Pacific Heart Institute

Santa Monica, California, 90404, United States

Location

Baptist Medical Center

Jacksonville, Florida, 32207, United States

Location

Rush University Medical Center

Chicago, Illinois, 60612, United States

Location

Prairie Education & Research Cooperative

Springfield, Illinois, 62769, United States

Location

Charlton Memorial Hospital

Fall River, Massachusetts, 02720, United States

Location

New York Presbyterian Hospital/Cornell University

New York, New York, 10021, United States

Location

Hightower Clinical

Oklahoma City, Oklahoma, 73102, United States

Location

University of Utah Hospital

Salt Lake City, Utah, 84132, United States

Location

Related Publications (1)

  • Reed SD, Yang JC, Wallace MJ, Sutphin J, Johnson FR, Ozdemir S, Delgado SM, Goates S, Harbert N, Lo M, Rajagopalan B, Ip JE, Al-Khatib SM. Patient Preferences for Features Associated With Leadless Versus Conventional Transvenous Cardiac Pacemakers. Circ Cardiovasc Qual Outcomes. 2024 Dec;17(12):e011168. doi: 10.1161/CIRCOUTCOMES.124.011168. Epub 2024 Nov 21.

MeSH Terms

Conditions

Arrhythmias, CardiacBradycardia

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Stephanie Delgado
Organization
Abbott Medical Devices

Study Officials

  • Shelby Reed, PhD

    Duke Clinical Research Institute

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 4, 2022

First Posted

April 14, 2022

Study Start

March 28, 2022

Primary Completion

June 13, 2023

Study Completion

June 13, 2023

Last Updated

February 20, 2025

Results First Posted

February 20, 2025

Record last verified: 2025-01

Locations